NO20003245L - <Kappa>-reseptor-opoidpeptider - Google Patents

<Kappa>-reseptor-opoidpeptider

Info

Publication number
NO20003245L
NO20003245L NO20003245A NO20003245A NO20003245L NO 20003245 L NO20003245 L NO 20003245L NO 20003245 A NO20003245 A NO 20003245A NO 20003245 A NO20003245 A NO 20003245A NO 20003245 L NO20003245 L NO 20003245L
Authority
NO
Norway
Prior art keywords
opoidpeptider
kappa
receptor
receptor opoidpeptider
Prior art date
Application number
NO20003245A
Other languages
English (en)
Other versions
NO327080B1 (no
NO20003245D0 (no
Inventor
Jean Louis Junien
Pierre J M Riviere
Claudio D Schteingart
Javier Sueiras Diaz
Jerzy A Trojnar
Todd W Vanderah
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20003245D0 publication Critical patent/NO20003245D0/no
Publication of NO20003245L publication Critical patent/NO20003245L/no
Publication of NO327080B1 publication Critical patent/NO327080B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003245A 1997-12-23 2000-06-21 Syntetisk opioidpeptidamid samt et farmasoytisk preparat NO327080B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides

Publications (3)

Publication Number Publication Date
NO20003245D0 NO20003245D0 (no) 2000-06-21
NO20003245L true NO20003245L (no) 2000-08-23
NO327080B1 NO327080B1 (no) 2009-04-20

Family

ID=25543752

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003245A NO327080B1 (no) 1997-12-23 2000-06-21 Syntetisk opioidpeptidamid samt et farmasoytisk preparat

Country Status (32)

Country Link
US (1) US5965701A (no)
EP (1) EP1042359B1 (no)
JP (1) JP4275852B2 (no)
KR (1) KR100629548B1 (no)
CN (1) CN1154655C (no)
AR (1) AR014167A1 (no)
AT (1) ATE301670T1 (no)
AU (1) AU747806B2 (no)
BR (2) BRPI9814499B8 (no)
CA (1) CA2315878C (no)
CR (1) CR5936A (no)
CZ (1) CZ297281B6 (no)
DE (1) DE69831176T2 (no)
DK (1) DK1042359T3 (no)
EE (1) EE04440B1 (no)
ES (1) ES2247735T3 (no)
HR (1) HRP20000415B1 (no)
HU (1) HU227640B1 (no)
IL (3) IL136742A0 (no)
MY (1) MY117542A (no)
NO (1) NO327080B1 (no)
NZ (1) NZ505183A (no)
PL (1) PL195842B1 (no)
PT (1) PT1042359E (no)
RU (1) RU2217437C2 (no)
SK (1) SK286135B6 (no)
TR (1) TR200001985T2 (no)
TW (1) TW580502B (no)
UA (1) UA68366C2 (no)
UY (1) UY25327A1 (no)
WO (1) WO1999032510A1 (no)
ZA (1) ZA9811801B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
JP4239592B2 (ja) * 2001-05-08 2009-03-18 東レ株式会社 敗血症治療剤
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
EP2040733A2 (en) * 2006-05-26 2009-04-01 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
CN101454338A (zh) * 2006-05-26 2009-06-10 卡拉治疗学股份有限公司 κ阿片样受体肽的N-氧化物
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
JP5244810B2 (ja) 2006-11-10 2013-07-24 カラ セラピューティクス インコーポレイテッド 合成ペプチドアミド
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
WO2008077194A1 (en) * 2006-12-22 2008-07-03 Xenome Ltd Receptor agonists
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
MX373659B (es) * 2014-06-26 2020-03-31 Maruishi Pharma Metodo para producir un pentapeptido sintetico.
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2016181408A2 (en) 2015-05-11 2016-11-17 Cadila Healthcare Limited NOVEL SHORT-CHAIN PEPTIDES AS KAPPA (κ) OPIOID RECEPTORS (KOR) AGONIST
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
CN109563133B (zh) * 2016-09-27 2020-09-11 四川科伦博泰生物医药股份有限公司 多酰胺化合物及其用途
BR112020001157A2 (pt) * 2017-07-21 2020-07-21 Sichuan Haisco Pharmaceutical Co., Ltd. compostos de peptídeo amida, método de preparação dos mesmos e uso em medicina
CN111065631B (zh) 2017-12-06 2021-10-08 江苏恒瑞医药股份有限公司 一种苯基丙酰胺类衍生物的盐及其制备方法
US20210205404A1 (en) 2018-05-16 2021-07-08 Jiangsu Hengrui Medicine Co., Ltd. Pharmaceutical composition of kor receptor agonist
CN114127086B (zh) * 2019-07-25 2023-10-20 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
CN114127085B (zh) * 2019-07-25 2024-08-13 西藏海思科制药有限公司 一种肽酰胺盐及其制备方法和在医药上的用途
CN114615976A (zh) * 2019-08-07 2022-06-10 人福医药美国公司 κ阿片受体肽酰胺激动剂
US12616732B2 (en) 2020-06-25 2026-05-05 Yichang Humanwell Pharmaceuticals Co., Ltd. Peptides for treatment of medical disorders
JP7577265B2 (ja) 2020-06-25 2024-11-05 ヒューマンウェル ファーマシューティカル ユーエス，インコーポレイテッド 医学的障害の治療のためのペプチド
US20240336565A1 (en) 2021-07-02 2024-10-10 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
NO327080B1 (no) 2009-04-20
EP1042359A1 (en) 2000-10-11
ZA9811801B (en) 1999-06-22
SK286135B6 (sk) 2008-04-07
RU2217437C2 (ru) 2003-11-27
DK1042359T3 (da) 2005-11-28
TR200001985T2 (tr) 2000-11-21
CZ297281B6 (cs) 2006-10-11
HUP0100626A2 (hu) 2001-08-28
CA2315878C (en) 2010-11-16
PL195842B1 (pl) 2007-10-31
HRP20000415B1 (en) 2004-06-30
HU227640B1 (en) 2011-10-28
UY25327A1 (es) 2000-12-29
WO1999032510A9 (en) 1999-09-23
AU747806B2 (en) 2002-05-23
CN1283201A (zh) 2001-02-07
CA2315878A1 (en) 1999-07-01
IL136742A (en) 2006-12-31
NO20003245D0 (no) 2000-06-21
BRPI9814499A (pt) 2000-10-10
JP2001526295A (ja) 2001-12-18
HRP20000415A2 (en) 2000-12-31
SK9602000A3 (en) 2001-01-18
CZ20002382A3 (cs) 2000-12-13
AR014167A1 (es) 2001-02-07
AU1940299A (en) 1999-07-12
KR100629548B1 (ko) 2006-09-27
UA68366C2 (en) 2004-08-16
US5965701A (en) 1999-10-12
ATE301670T1 (de) 2005-08-15
IL136742A0 (en) 2001-06-14
BRPI9814499B8 (pt) 2021-11-09
DE69831176T2 (de) 2006-04-20
CR5936A (es) 2006-08-18
IL178471A0 (en) 2007-02-11
EE04440B1 (et) 2005-02-15
BRPI9814499B1 (pt) 2014-10-21
KR20010033450A (ko) 2001-04-25
EE200000370A (et) 2001-10-15
MY117542A (en) 2004-07-31
JP4275852B2 (ja) 2009-06-10
HUP0100626A3 (en) 2001-12-28
BR9814499A (pt) 2000-10-10
TW580502B (en) 2004-03-21
ES2247735T3 (es) 2006-03-01
BR9814499B1 (pt) 2014-10-21
EP1042359B1 (en) 2005-08-10
PL341308A1 (en) 2001-04-09
NZ505183A (en) 2001-09-28
CN1154655C (zh) 2004-06-23
DE69831176D1 (de) 2005-09-15
WO1999032510A1 (en) 1999-07-01
PT1042359E (pt) 2005-11-30
HK1029349A1 (en) 2001-03-30

Similar Documents

Publication Publication Date Title
NO20003245D0 (no) &lt;Kappa&gt;-reseptor-opoid-peptider
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
ATE250583T1 (de) Substituierte 3-cyanochinoline
FI974092L (fi) Paikallisverkko
DE69831821D1 (de) Hochleitungs-zweischichtigesreibungsmaterial
ID23168A (id) Reseptor anatagonis vitronektin
ID26211A (id) Sambungan berbentuk tabung
NO20001494D0 (no) Overligger
DE69806167D1 (de) Ausgiessvorrichtung
NO20013997L (no) Reseptoranalyse
DE69827969D1 (de) Ausgiessvorrichtung
DE69826125D1 (de) Fixiergerät
DE19882848T1 (de) Reaktor
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
FR2761451B1 (fr) Raccord de tube
ID22642A (id) Reaktor
DE69841297D1 (de) Toner
NO981454L (no) Anti-FAS-antistoffer
ID20253A (id) Reaktor
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
DE69825927D1 (de) Fixiereinrichtung
DK0960100T3 (da) Substituerede 4-benzoyl-pyrazoler
NO994838D0 (no) &lt;pi&gt;-kompleks-forbindelser
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees